Skip to main content
PLOS One logoLink to PLOS One
. 2022 Apr 7;17(4):e0266485. doi: 10.1371/journal.pone.0266485

Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand

Geoff Kaine 1,*,#, Vic Wright 2,#, Suzie Greenhalgh 3,#
Editor: Sonia Brito-Costa4
PMCID: PMC8989211  PMID: 35390053

Abstract

Governments around the world are seeking to slow the spread of Covid-19 and reduce hospitalisations by encouraging mass vaccinations for Covid-19. The success of this policy depends on most of the population accepting the vaccine and then being vaccinated. Understanding and predicting the motivation of individuals to be vaccinated is, therefore, critical in assessing the likely effectiveness of a mass vaccination programme in slowing the spread of the virus. In this paper we draw on the I3 Response Framework to understand and predict the willingness of New Zealanders to be vaccinated for Covid-19. The Framework differs from most studies predicting willingness to be vaccinated because it is based on the idea that the willingness to adopt a behaviour depends on both involvement (a measure of motivational strength) with the behaviour and attitudes towards the behaviour. We show that predictions of individuals’ willingness to be vaccinated are improved using involvement and attitudes together, compared to attitudes alone. This result has important implications for the implementation of mass vaccination programmes for Covid-19.

Introduction

The success of measures to slow or stop the spread of Covid-19, such as wearing masks, using tracer apps, and mass vaccination, depends on the commitment and capacity of individuals to accept them and change their behaviour accordingly. For example, failure to achieve high rates of vaccinations for Covid-19 may mean the recurrent imposition of lockdowns (which cause economic, social, and psychological damage) and continued investment of considerable resources in contact tracing, community testing, operating quarantine facilities, and the diversion of medical infrastructure and services to combat increased rates of infection and hospitalisation from Covid-19. Hence, understanding and predicting the extent to which individuals are motivated to participate in a mass vaccination programme is critical in assessing the likely effectiveness of the programme.

There is an extensive literature on people’s willingness to be vaccinated, especially in regard to vaccine hesitancy [16], which shows that beliefs about, and attitudes towards, vaccines are fundamental to people’s acceptance of vaccines and their willingness to be vaccinated. Consequently, this literature points to education and promotion as key strategies for changing awareness, beliefs, and attitudes to vaccine hesitancy and encouraging participation in vaccination programmes [3, 68]. The success of these strategies depends on how malleable people’s attitudes are [9] and how attentive they are to education and promotion activities [1012].

In this paper we draw on the I3 Response Framework [6] to predict how strongly New Zealanders are motivated to be vaccinated for Covid-19, and to investigate differences in the strength and stability of New Zealanders’ attitudes towards being vaccinated for Covid-19. We then draw out implications for how attentive New Zealanders might be to education and promotion activities that encourage their participation in a mass vaccination programme for Covid-19.

Theory

Kaine et al. [13] proposed that theories about people’s responses to policy measures, such as urgings to get vaccinated, implicitly presume that the measures are inherently important enough to people that they devote considerable cognitive effort to gathering information about the measure, processing that information, formulating attitudes towards the measure, and reaching a decision about whether to comply (in the broadest sense of the word) with the measure or not. Kaine et al. [13] suggested that these theories cannot be expected to predict behaviour accurately when this presumption is invalid, and when the subject (e.g. being vaccinated against Covid-19) is not perceived to be important enough (i.e. sufficiently relevant to people’s personal goals) to trigger the effort required to form an attitude that has the power to influence their behaviour. Consequently, to predict how people may or may not respond to any given policy measure it is necessary to understand whether they are likely to invest effort in decision-making regarding that measure.

As explained in detail in Kaine et al. [13], the effort people will devote to decision-making about complying with a policy measure will depend on their involvement with the policy issue (in this case, the policy outcome of eliminating Covid-19 from New Zealand) and the intervention (the policy measure, such as being vaccinated for Covid-19), with the former being an important component of the context for the latter. These concepts underpin the I3 Response Framework (involvement, issue, and intervention, hence I3) used in this analysis.

The behaviour changes to be analysed with the I3 Framework occur in a public policy rather than a commercial context. This means the outcome(s) sought are typically declared, and government, or its agencies, intervene with measures designed to modify behaviour in pursuit of the outcome(s). Either compulsion or voluntary responses may be involved, but compliance is central to achieving outcomes. In what follows in this section we have drawn extensively on the discussion of the interpretation of Framework findings from Kaine et al. [13] to make it readily accessible for the reader.

The I3 framework

Kaine et al. [13] proposed that people’s responses to policy measures can be inferred from their:

  • involvement with the relevant policy outcome which, in this context, is involvement with preventing the spread of Covid-19 (not involvement with Covid-19 per se)

  • involvement with, and attitude towards, the policy measure itself which, in this context, is getting vaccinated against Covid19.

Involvement with the policy measure signals the degree to which the measure itself is a source of motivation for the individual, irrespective of the policy issue [14, 15]. This allows for the possibility that individuals are motivated to act in response to a measure even though they do not perceive that the policy outcome the measure addresses is relevant to them. In such situations it may be that the wish to comply is motivated by involvement with some other outcome, such as conforming with social norms [16].

However, the perceived relevance of a policy outcome is relevant to an individual’s cognitions about related measures. One would normally expect a positive correlation between involvement with the outcome and the measure while recognising the possibility of variation in involvement across various measures. The value of the Framework is that it enables a decomposition of overall involvement with a policy outcome and corresponding measures, as well as distinguishing between involvement with different measures and closer analysis of the role of beliefs held by individuals, as informational contexts for attitudes. This has implications for the relevance of the various components of vaccination hesitancy, which we refer to in our description of the Framework below.

The two dimensions of involvement with the policy outcome and involvement with the policy measure mean that the responses of people to a policy measure can be classified into four quadrants, as shown in Fig 1.

Fig 1. Map and explanation of quadrants in the I3 response framework.

Fig 1

People in quadrant 1 exhibit low involvement with both the policy outcome and the policy measure. Consequently, these people are hypothesised to have little knowledge, or even awareness, of the policy outcome and are likely to have limited knowledge of the policy measure, and to have weak attitudes towards it, if any at all. These people may be either detached because they have other interests and concerns, or they are ‘know-nothings’: they do not particularly care about or have any interest in the outcome [17]. Chaffee and Roser [18, p. 376] describe this behaviour as being ‘a direct response to situational constraints and not especially reflective of one’s attitudes or knowledge.’ Therefore, for these people, non-compliance with the measure is largely unintentional [19].

In the context we are considering here, the low involvement of people in quadrant 1 with the policy outcome of eliminating Covid-19 and getting vaccinated has important implications for overcoming vaccine hesitancy. In recent models of vaccine hesitancy such as the 5C model, hesitancy is decomposed into five components: confidence, complacency, constraints, calculation, and collective responsibility [5]. According to Wismans et al. [6]:

  • confidence relates to trust in the effectiveness and safety of vaccines, in the system that delivers them, and in the motivations of policymakers;

  • complacency reflects the perceived risk and perceived level of threat of vaccine-preventable diseases;

  • constraints are psychological and physical barriers, such as accessibility, health literacy, and affordability;

  • calculation relates to individuals’ engagement in extensive information searching; and

  • collective responsibility reflects a willingness to protect others by getting vaccinated.

Confidence and complacency, and potentially constraints and collective responsibility, depend on awareness and beliefs. Given their lack of interest, people in quadrant 1 could be expected to be indifferent with respect to confidence in vaccines, complacent with respect to personal risk, sensitive to constraints on being vaccinated, unengaged with calculation, and indifferent to collective responsibility.

If the proportion of people in quadrant 1 is low enough to present little threat to achieving the aggregate policy outcome of preventing the spread of Covid-19, they can be ignored [13]. Otherwise, their compliance with the measure (getting vaccinated) may be encouraged by:

  • linking the policy outcome to a subject they find more involving (e.g. concern for family, employment, recreation, international travel);

  • reducing the effort required to be compliant (e.g. offering vaccinations in convenient locations such as shopping malls, churches, and sports venues, or offering free vaccinations);

  • offering incentives (e.g. cash and other rewards);

  • promoting awareness of, and building knowledge about, the policy outcome and the policy measure.

However, because people in this quadrant are uninterested, they are unlikely to pay attention to promotional and educational messaging, so the final strategy of promoting awareness is likely to be ineffective. Kim [14] suggests that an affect-evoking strategy (i.e. one that evokes an emotional response) should be the most effective means of attracting people’s attention under these circumstances. This is likely to be achieved by focusing the affect-evoking strategy on the policy outcome, as greater involvement with the outcome is likely to engender greater involvement with individual measures.

People in quadrant 2 exhibit high involvement with the policy outcome but low involvement with the measure. Consequently, they would be aware of the outcome and invest time and energy in processing information, decision-making, and responding to the outcome [18, 20]. They may have limited knowledge of the policy measure and may have weak or ambivalent attitudes towards it. Any non-compliance with the measure is largely unintentional [13].

Regarding vaccine hesitancy [6], people in quadrant 2 could be expected to be unsure or indifferent with respect to confidence in vaccines, may be complacent with respect to personal risk because they are young and healthy and/or they feel the likelihood of exposure is low because the incidence of transmission in the community is low. They may be somewhat sensitive to constraints on being vaccinated, modest on calculation, but have some sense of collective responsibility.

If people in quadrant 2 represent little risk in terms of achieving the policy outcome, they can be ignored. If their compliance is important to achieving the policy outcome, reducing the effort required for compliance [21] and promoting awareness of the policy measure may be worthwhile. This can be done by taking advantage of the intensity of their involvement with the policy outcome, particularly when this is accompanied by favourable attitudes towards the measure.

People in quadrant 3 exhibit high involvement with both the policy outcome and the measure. These people are likely to have extensive and detailed knowledge of the policy outcome. They are also likely to have extensive knowledge of the policy measure and strong attitudes towards it [20]. If their attitude towards the policy measure is favourable, they will comply with the measure and may even advocate for it [13]. Consequently, a strategy for promoting compliance among individuals in this quadrant with a favourable attitude might focus on self-regulation. Promotion and monitoring may also be worthwhile to ensure awareness and knowledge of obligations, ensure desirable behaviours are maintained, and identify at an early stage any changes in their attitude [13].

In terms of vaccine hesitancy [6], people in quadrant 3 could be expected to be polarised. If people in this quadrant had a favourable attitude towards vaccines then we would expect them to have high confidence in vaccines, be non-complacent with respect to personal risk, be insensitive to constraints on being vaccinated, be thoroughly engaged with calculation, and have a strong sense of collective responsibility. People in this quadrant with an unfavourable attitude towards vaccines could be expected to have low confidence in vaccines, be non-complacent with respect to personal risk, be insensitive to constraints on being vaccinated, be thoroughly engaged with calculation, and have a weak sense of collective responsibility in terms of willingness to protect others by getting vaccinated.

If people in quadrant 3 have an unfavourable attitude towards the policy measure, they may comply, but reluctantly [13]. Non-compliance with the measure will be intentional. Most likely they will prefer–and even advocate for–an alternative policy measure. Where practical, incorporating these changes may encourage compliance among these people [22]. Alternatively, offering incentives to reduce compliance costs may neutralise unfavourable reactions.

Another strategy for promoting compliance among people in this quadrant with an unfavourable attitude is to change their attitude towards the measure. This may be possible by reframing the benefits about the measure in terms of another subject that is more involving for them [13], thus provoking a recalculation of net costs and benefits. Alternatively, a promotional programme could be implemented with the outcome of persuading these people that they are mistaken, and that the behaviour required by the policy measure (being vaccinated) is superior to any alternatives. This strategy is likely to fail if people in this quadrant hold strongly favourable, or unfavourable, attitudes as they are likely to engage in motivated reasoning [11, 12]; i.e., filtering out information that challenges their beliefs and attitudes. Finally, compliance among these individuals might be increased by investing resources in enforcement, to increase the likelihood of detection and prosecution, and legislating severe penalties for non-compliance. However, authorities would need to carefully consider the imposition of blanket penalties for non-compliance because they run the risk of incidentally alienating people with low involvement.

Note that if the causes of non-compliance relate to unpredictable variations in the environment, or to unforeseeable technical problems, then enforcement and general deterrence may be ineffective. A more appropriate strategy in these circumstances may be to focus on the provision of technical assistance [23, 24].

People in quadrant 4 exhibit low involvement with the policy outcome but high involvement with the measure. People in this quadrant are likely to have limited knowledge of the policy outcome. They are likely to have detailed knowledge of the policy measure and have strong attitudes towards it [20]. If their attitude towards the measure is favourable, they will comply with the measure [13]. In these circumstances the government agency may play a monitoring role to check that the conditions promoting compliance do not change. A promotional strategy to support and reinforce compliance behaviour may also be worthwhile.

On the other hand, if the members of this quadrant have an unfavourable attitude towards the policy measure, they will only comply reluctantly, or may intentionally refuse to comply at all. These people will regard the measure as intrusive and as imposing unwarranted costs upon them. Most likely they will agitate against the policy measure [13] because they are not committed to the outcome. One strategy for promoting compliance among these individuals is to change their attitude towards the measure. This may be possible by reframing it in terms of another, more involving subject [13]. Offering incentives to offset compliance costs, or delaying or staging the introduction of policy measures, may neutralise unfavourable reactions [22]. Finally, compliance among these individuals might be increased by investing resources to increase the likelihood of detection and prosecution of non-compliance, and by introducing severe penalties. Again, as mentioned earlier, authorities would need to carefully consider the imposition of blanket penalties for non-compliance because they run the risk of incidentally alienating people with low involvement.

With respect to vaccine hesitancy [6], people in quadrant 4 could be expected to be polarised. People in this quadrant with a favourable attitude towards vaccines could be expected to have high confidence in vaccines, be variably complacent with respect to personal risk, be insensitive to constraints on being vaccinated, be thoroughly engaged with calculation, and be variable in their sense of collective responsibility (especially those who view vaccination purely in terms of personal protection). People in this quadrant with an unfavourable attitude towards vaccines could be expected to have low confidence in vaccines, be variably complacent with respect to personal risk, be insensitive to constraints on being vaccinated, be thoroughly engaged with calculation, and have a weak sense of collective responsibility in terms of willingness to protect others by getting vaccinated.

In summary, Kaine et al. [13] hypothesised that individual responses to policy measures will depend on the intensity and source of involvement of the individual with the measure and, where that involvement is sufficiently intense to form an attitude, on whether that attitude is favourable or unfavourable. In a specific applied setting, such as a policy to control the spread of Covid-19, the I3 Framework enables the prediction of people’s likely compliance with measures such as willingness to participate in a mass vaccination programme and, given the reasons for their involvement and their attitudes, the best ways to enhance that compliance. The I3 Framework has been employed to understand and predict compliance behaviour in a variety of contexts in agriculture [19, 23, 25, 26], rural and urban predator control [27, 28], and community support for predator control [29, 30].

Covid-19 in New Zealand

Covid-19 was first detected in New Zealand on 28 February 2020 [31]. Within 3 weeks the central government had closed New Zealand’s international border to all except returning citizens and permanent residents. The government began pursuing a restrictive strategy [32] of eliminating Covid-19 and applied a range of control measures to stop the transmission of Covid-19 in New Zealand [33]. Elimination did not necessarily mean eradicating the virus permanently from New Zealand; rather, that central government was confident chains of transmission in the community had been eliminated for at least 28 days, and any cases imported from overseas in the future could be effectively contained [33].

The central government commenced a mass vaccination programme for Covid-19 using the Pfizer vaccine, starting with border and managed isolation and quarantine workers, in February 2021 [34]. The programme was accompanied by an extensive, government-funded publicity campaign using traditional and social media. The survey in this study was completed during the first and second week of March 2021 before vaccinations were available to the general public.

Materials and methods

Given the reasoning underpinning the I3 Response Framework [13], our purpose in this paper was to investigate the extent to which the willingness of New Zealanders to be vaccinated for Covid-19 depended on their involvement (a measure of motivational strength) with the idea of eliminating Covid-19 and with the idea of being vaccinated, as well as their attitudes (which depend on their beliefs) towards these ideas. Consequently, a questionnaire seeking information from the public on their beliefs about, attitudes towards, and willingness to be vaccinated against, Covid-19 was designed based on the I3 Response Framework [13]. The questionnaire is reproduced in S1 File.

Involvement with eliminating Covid-19 from New Zealand and involvement with getting vaccinated against Covid-19 were each measured using a condensed version of the Laurent and Kapferer [35] involvement scale developed by Kaine [36], with respondents rating two statements on each of the five components of involvement (functional, experiential, identity-based, consequence-based, and risk-based). Functional involvement arises from utilitarian and economic needs and experiential involvement arises from pleasure needs. Identity involvement concerns self-concept and impression management needs. The intensity of involvement is also be amplified by an individual’s perception of the seriousness of making mistakes in relation to those needs, and the risks of making such mistakes [13].

Attitudes were measured using a simple, evaluative scale, while the strength of respondents’ attitudes, which were expected to vary depending on the strength of their involvement, was measured using an ipsative scale based on Olsen [37]. A series of questions was formulated to elicit respondents’ beliefs about Covid-19, eliminating Covid-19, and getting vaccinated for Covid-19.

The ordering of the statements within each of the involvement, attitude, and belief scales was randomised to avoid bias in responses. Respondents indicated their agreement with statements in all the involvement, attitude, and belief scales using a five-point rating, ranging from strongly disagree (1) to strongly agree (5). Involvement scores were computed as the simple arithmetic average of respondents’ agreement ratings for the ten statements in the involvement scales. Attitude scores were computed as the simple arithmetic average of respondents’ agreement ratings for the five statements in the attitude scales. Belief scores were simply respondents’ agreement ratings on each belief statement. The internal consistency of the involvement and attitudinal scales was assessed using Cronbach’s alpha [38].

Respondents were asked whether they were willing to get vaccinated against Covid-19 and to indicate their willingness using a five-point rating, ranging from ‘definitely not’ (1) to ‘definitely’ (5). Respondents who answered that they might, probably would or definitely would get vaccinated were also asked if they would get vaccinated as soon as possible and whether they would get vaccinated even if the vaccine only offered a few months protection.

Respondents were questioned about the policy outcome of eliminating Covid-19 from New Zealand. They were asked whether they felt some responsibility for eliminating Covid-19 from New Zealand, were prepared to change their normal behaviour or to make sacrifices to eliminate Covid-19 from New Zealand and if it was important to work together to eliminate Covid-19 from New Zealand. Respondents indicated their agreement with these policy outcome statements using a five-point rating, ranging from ‘strongly disagree’ (1) to ‘strongly agree’ (5).

Information was sought on the demographic characteristics of respondents, including age, education, and ethnicity, and whether they were willing to be vaccinated for Covid-19. The ethnicity categories were Māori (the indigenous people of New Zealand), European New Zealander, Pacific Islander, Asian, and Other.

Participation in the survey was voluntary, respondents could leave the survey at any time, and all survey questions were optional and could be skipped. The research approach was reviewed and approved by social ethics process of Manaaki Whenua–Landcare Research (application no. 2021/27), which is based on the New Zealand Association of Social Science Research code of ethics.

The questionnaire, stratified by regional population, was distributed from 4 March to 15 March 2021 to a random sample of New Zealanders who were members of an online consumer panel. Panel members receive reward points (which are redeemable for products and services) for completing surveys. A total of 1,002 completed responses were obtained within the two-week period of which 53% were from women and 47% from men.

The age distribution aligned closely with the 2018 Census distribution, but Māori and Pacific Island residents were under-represented in the sample while ‘other’ ethnicities were over-represented. The household income distribution of the sample approximated the distribution from the 2018 Census. Residents with secondary or certificate qualifications were substantially under-represented in the sample, while residents with graduate and postgraduate qualifications were substantially over-represented (see S1 Appendix).

At the time the survey was conducted Auckland residents were under Alert Level 2, which meant they were expected to maintain social distancing when outside their homes and to wear masks in public places. They were also expected to keep track of their movements and to self-isolate and seek testing for Covid-19 if they felt unwell and experienced symptoms associated with Covid-19. The rest of the country was at Alert level 1 during this time. At Alert Level 1 social distancing and the wearing of face masks in public places is not expected. People are encouraged to keep track of their movements and to self-isolate and seek testing for Covid-19 if they feel unwell and experience symptoms associated with Covid-19.

Given these circumstances and given that the pandemic had been receiving widespread coverage by traditional and social media in New Zealand since February 2020, it seems reasonable to suppose that virtually all respondents were aware of Covid-19 at the time we conducted our survey and that most, if not all, were also aware of the government intention to institute a mass vaccination programme. While awareness of the existence of Covid-19 is a prerequisite for involvement with it, awareness does not necessarily entail involvement. Widespread awareness of Covid-19 simply creates the potential for widespread involvement. The extent to which that potential is realised depends on respondents’ beliefs about how Covid-19 could affect the achievement of their functional, experiential, and self-identity needs.

The data were analysed in three stages. First, the expected associations between I3 quadrant membership and willingness to be vaccinated were investigated. Respondents were allocated to quadrants depending on whether their involvement scores were less than, or more than, the mid-point of the scale (i.e. 3.00) and differences investigated in respondents’ willingness to be vaccinated were investigated across the quadrants. We also explored differences across the quadrants in variables relating to the 5C model of vaccine hesitancy. Statistically significant differences among quadrants were identified using chi-square and analysis-of-variance tests as appropriate.

The purpose of the second stage of the analysis was to conveniently summarise respondents’ beliefs about Covid-19, eliminating Covid-19 and getting vaccinated for Covid-19 for inclusion in the third stage of the analysis. Respondents were classified into three sets of segments using cluster analysis. The first set of segments was based on respondents’ beliefs about Covid-19, the second set was based on their beliefs about eliminating Covid-19 and the third set was based on their beliefs about Covid-19 vaccines. Respondents were clustered into belief segments based on their agreement ratings with the set of relevant belief statements using Ward’s method, with squared Euclidean distance as the measure of dissimilarity [39]. The number of segments was chosen based on the relative change in fusion coefficients, ease of interpreting the segments, and a desire to keep the number of segments as small as possible [39]. Statistically significant differences in beliefs among segments were identified using Tukey’s HSD test [40].

In the third stage, using regression analysis, we quantified the effect of beliefs, attitudes, and involvement on respondents’ support for the policy outcome of eliminating Covid-19 from New Zealand and on their propensity to be vaccinated for Covid-19. For this stage dummy variables were created representing respondents’ membership of the belief segments identified in stage two with respect to Covid-19, eliminating Covid-19 and getting vaccinated for Covid-19. For each set, the relevant ‘sceptics’ segment was treated as the benchmark. Ordinary Least Squares and Binary logistic regressions were used in this stage of the analysis.

Statistical analyses were conducted using the ‘cluster’ and ‘regression’ commands in SPSS [41].

Results

Stage 1: I3 membership and willingness to be vaccinated

As shown in Table 1, all of the involvement and attitudinal scales exhibited satisfactory reliabilities [38]. For convenience degrees of involvement were categorised as low (score less than 2), mild (score greater than 2 but less than 3), moderate (score greater than 3 but less than 4) and high (score greater than 4). Most respondents had moderate-to-high involvement with eliminating Covid-19 from New Zealand and with getting vaccinated and so were placed in quadrant 3 (Table 2). However, a substantial minority of respondents had low-to-mild involvement with getting vaccinated for Covid-19 and so were placed in quadrants 1 and 2.

Table 1. Reliability of involvement and attitude scales.

Reliability
Involvement with eliminating Covid-19 0.847
Involvement with being vaccinated for Covid-19 0.852
Attitude towards being vaccinated for Covid-19 0.854

Notes: Values are Cronbach’s alpha [38].

Table 2. I3 classification for being vaccinated for Covid-19.

Percentage of respondents
Quadrant 1 4.8
Quadrant 2 7.4
Quadrant 3 86.7
Quadrant 4 1.1
Total 100.0

A majority of respondents exhibited a strongly favourable attitude, as measured by the ipsative attitude scale, towards being vaccinated for Covid-19 (Table 3). These results suggest that only a small proportion of respondents would deliberately choose not to be vaccinated to protect themselves and help prevent the spread of Covid-19 in the community.

Table 3. I3 vaccine classification and attitude towards being vaccinated.

Attitude Quadrant 1 Quadrant 2 Quadrant 3 Quadrant 4 Sample
Right thing to do 12.5 21.6 74.0 54.5 67.0
Doesn’t matter to me 8.3 9.5 5.3 9.1 5.8
Not sure 35.4 44.6 16.7 9.1 19.6
Haven’t given it much thought 12.5 4.1 3.0 9.1 3.6
Bad thing to do 31.3 20.3 1.0 18.2 4.1

Notes: Values are percentages of respondents in each quadrant. Test for differences in percentages across quadrants (χ2 = 259.1, P < 0.01).

Consistent with involvement theory, a relatively high proportion of respondents in quadrant 1 and quadrant 2 were unsure whether getting vaccinated was the right thing to do. Consequently, a relatively low proportion of these respondents indicated they were likely to be willing to be vaccinated (Table 4), and those that were willing were less sure of being vaccinated immediately once vaccines were available (Table 5) or to be vaccinated if vaccines only offered a few months’ protection (Table 6). By contrast, and consistent with theory, a high proportion of the respondents in quadrant 3 were sure that being vaccinated was the right thing to do (Table 3), were willing to be vaccinated (Table 4), and as quickly as possible, once vaccines were available (Table 5). A high proportion of these respondents was willing to be vaccinated if vaccines only offered a few months’ protection (Table 6). These results and their implications for government policy are discussed in detail by Kaine [42].

Table 4. I3 vaccine classification and willingness to be vaccinated.

Quadrant 1 Quadrant 2 Quadrant 3 Quadrant 4 Sample
Definitely 12.5 9.5 56.7 36.4 50.9
Probably 6.3 16.2 20.0 18.2 19.1
Maybe 16.7 24.3 16.7 18.2 17.3
Probably not 16.7 23.0 4.9 9.1 6.9
Definitely not 47.9 27.0 1.6 18.2 5.9

Notes: Values are percentages of respondents in each quadrant or total sample. Test for differences in percentages across quadrants (χ2 = 321.6, P < 0.01).

Table 5. I3 vaccine classification and willingness to be vaccinated as soon as possible.

Quadrant 1 Quadrant 2 Quadrant 3 Quadrant 4 Sample
Yes 41.2 18.9 68.2 75.0 65.7
Not sure 29.4 29.7 21.6 25.0 22.1
No 29.4 51.4 10.2 0.0 12.2

Notes: Values are percentages of respondents in each quadrant (or the total sample) who indicated they definitely or probably would, or might, get vaccinated. Test for differences in percentages across quadrants (χ2 = 70.3, P < 0.01).

Table 6. I3 vaccine classification and willingness to be vaccinated even if it only offers a few months’ protection.

Quadrant 1 Quadrant 2 Quadrant 3 Quadrant 4 Sample
Yes 33.3 27.8 61.2 50.0 59.8
Not sure 25.0 33.3 26.3 37.5 26.6
No 41.7 38.9 12.5 12.5 13.6

Notes: Values are percentages of respondents in each quadrant (or the total sample) who indicated they definitely or probably would, or might, get vaccinated and excludes those who indicated they would not get vaccinated as a soon as possible. Test for differences in percentages across quadrants (χ2 = 21.7, P < 0.01).

The predominantly moderate-to-high involvement with, and favourable attitudes of most respondents towards, being vaccinated to help eliminate Covid-19 from New Zealand is consistent with the high level of community endorsement of the New Zealand Government’s approach to managing Covid-19 [43] and the cumulative proportion of the population that has been vaccinated or is booked to be vaccinated [34].

I3 membership and the 5C model

Although this study was not designed to investigate relationships between the I3 Framework and models of vaccine hesitancy such as the 5C model, and bearing in mind that we were not using the standard scales that have been developed for that model [5], we were able to examine some of the suggestions made earlier about these relationships. We found differences in beliefs broadly in line with our expectations about differences in confidence, complacency, constraints, and collective responsibility across the quadrants (Tables 7 and 8). We also found differences across the quadrants in media use that aligned with our expectations about differences in calculation.

Table 7. I3 vaccine classification, confidence, complacency, and constraints.

Quadrant 1 Quadrant 2 Quadrant 3 Quadrant 4
Confidence: 4.00 3.54 2.61 a 3.09
It isn’t worth getting vaccinated against Covid-19 yet as there are too many unknowns about the vaccines
Children shouldn’t be vaccinated against Covid-19 3.52 3.14 2.45 a 2.64
I think we should wait and see if the Covid-19 vaccination works overseas before trying it here 3.50 3.61 2.83 a, b 3.36
Getting vaccinated against Covid-19 is unsafe because of the potential side-effects 3.48 3.39 2.51 a, b 2.82
Complacency: 2.38 1.95 1.57 a, b 2.18
I think Covid-19 is a hoax
Fears about Covid-19 are exaggerated 3.83 2.73 a 2.15 a, b 3.36 c
Covid-19 is no worse than the seasonal flu 3.10 2.47 a 1.99 a, b 2.18
Constraints: 2.98 2.27 2.14 a, b 2.73
Getting vaccinated against Covid-19 is just not practical
Getting vaccinated against Covid-19 isn’t worthwhile if you are only protected for a few months 3.77 3.43 2.71 a, b 3.18
Getting vaccinated against Covid-19 is a waste of time and effort 3.10 2.81 1.99 a, b 2.64

Notes: Agreement with a statement was rated on a five-point scale from strongly disagree (1) to strongly agree (5).

Differences in mean agreement ratings between segments tested using Tukey’s HSD [40], (P < 0.01).

a Mean agreement rating significantly different from mean for quadrant 1.

b Mean agreement rating significantly different from mean for quadrant 2.

c Mean agreement rating significantly different from mean for quadrant 3.

Table 8. I3 vaccine classification, calculation, and collective responsibility.

Quadrant 1 Quadrant 2 Quadrant 3 Quadrant 4
Calculation: 33.3 20.3 10.2 27.3
Respondents who did not watch, read, or listen for news about Covid-19 on traditional media (%) a
Respondents who did not watch, read, or listen for news about Covid-19 on social media (%) b 70.8 51.4 50.3 54.5
Respondents who did not chat about Covid-19 with family, friends, or co-workers in the past week (%) c 45.8 31.1 22.1 45.5
Number of modes of traditional media (e.g., television, radio, magazines) viewed 0.88 1.27 1.53 d 1.09
Number of social media sources (e.g., Facebook, Instagram) viewed 0.37 0.72 0.85 d 0.64
Collective responsibility: 2.54 3.89 4.22 d, e 2.55 e, f
We need to eliminate Covid-19 from New Zealand to save lives
We should just live with Covid-19 until we have a vaccine 3.42 2.74 d 2.53 d 3.36
It would be better to let Covid-19 spread and build herd immunity 3.54 2.43 d 1.99 d, e 3.09 f
You should only have to get vaccinated if you are old or have a health problem 2.79 2.53 2.18 d, e 2.45

Notes: Agreement with a statement was rated on a five-point scale from strongly disagree (1) to strongly agree (5).

Differences in mean agreement ratings between segments tested using Tukey’s HSD [40], (P < 0.01).

a Test for differences in percentages across quadrants (χ2 = 29.8, P < 0.01).

b Test for differences in percentages across quadrants (χ2 = 7.7, P < 0.05).

c Test for differences in percentages across quadrants (χ2 = 19.0, P < 0.01).

d Mean agreement rating significantly different from mean for quadrant 1.

e Mean agreement rating significantly different from mean for quadrant 2.

f Mean agreement rating significantly different from mean for quadrant 3.

For example, compared to respondents in quadrant 3, respondents in quadrant 1 appeared:

  • less confident about the safety of Covid-19 vaccines (confidence);

  • to regard Covid-19 as less threatening (complacency);

  • to believe being vaccinated was impractical and not worthwhile (constraints);

  • to consult fewer traditional and social media (calculation); and

  • less sure that healthier and younger people needed to be vaccinated (collective responsibility)

Stage 2: Belief segments

Respondents’ beliefs were investigated because they can provide insights to guide the design of policies that, by modifying the beliefs and attitudes that underlie compliance, seek to influence compliance. Using respondent agreement ratings for the relevant set of belief statements, respondents were first classified into a set of segments with respect to their beliefs about the nature of Covid-19. Next, they were classified into a second set of segments based on their beliefs about eliminating Covid-19. Lastly, they were classified into a third set of segments based on their beliefs about the advantages and disadvantages of Covid-19 vaccines. The segments, and their belief characteristics, are summarised below.

Beliefs about Covid-19, eliminating Covid-19, and getting vaccinated for Covid-19 were associated, to some extent, with demographic characteristics such as age, education, income, and ethnicity (see [42] for details).

Belief segments for Covid-19

Respondents were clustered into five belief segments with respect to Covid-19 (Table B1 in S2 Appendix). Note that the survey was conducted before the widespread emergence of the delta variant of Covid-19. Most respondents had beliefs that align with accepted scientific facts. These respondents were classified as ‘Covid-19 convinced’ (37%) and ‘Covid-19 moderates’ (40%), the difference between these two segments being the intensity of their beliefs. The ‘Covid-19 asymptomatics’ (9%) had beliefs that mostly align with accepted scientific facts, but these respondents either disagreed that Covid-19 was spread by people coughing and sneezing or by contact with surfaces touched by infected people. This may reflect an awareness that Covid-19 can be transmitted by people with Covid-19 who are asymptomatic, and an awareness that the likelihood of infection by contact with contaminated surfaces is low. A fourth segment, the ‘Covid-19 ambivalents’ (12%), consisted of respondents who were unsure about what to believe about Covid-19. A small segment of respondents, the ‘Covid-19 sceptics’ (6%), believed that Covid-19 is a hoax, is no worse than the seasonal flu, and that fears about Covid-19 are exaggerated.

Belief segments for eliminating Covid-19

Respondents were clustered into four belief segments with respect to eliminating Covid-19 (Table B2 in S2 Appendix). Most respondents have beliefs that align with seeking to eliminate Covid-19 from New Zealand. These respondents were classified as ‘elimination enthusiasts’ (26%) and ‘elimination moderates’ (18%), the difference between these two segments being the intensity of their beliefs. Another segment of respondents, the ‘vaccination hopefuls’ (34%), agreed with trying to eliminate Covid-19 but were less sure that Covid-19 could be kept out of New Zealand indefinitely. They believed we must live with Covid-19 until a vaccine is available. We did not define what the characteristics of a vaccine, once available, would be. A fourth segment, the ‘elimination sceptics’ (22%), consisted of respondents who believe we cannot eliminate Covid-19 indefinitely and we should try to build herd immunity.

Belief segments for Covid-19 vaccination

Respondents were clustered into five belief segments with respect to being vaccinated against Covid-19 (Table B3 in S2 Appendix). Approximately half the sample was classified as ‘vaccine enthusiasts’ (24%) or ‘vaccine moderates’ (33%), the difference between these two segments being the intensity of their beliefs. These respondents believed that you will recover faster from Covid-19, and have weaker symptoms, if you are vaccinated. They were unsure whether being vaccinated stops you catching or spreading Covid-19 or gives you lifelong protection. They believed everyone should be vaccinated, and it should be compulsory and free. They did not believe Covid-19 vaccines are unsafe or that vaccinations should wait until experience overseas demonstrates that they work.

A third segment of respondents, the ‘vaccination cautious’ (7%), fundamentally favoured being vaccinated but were concerned about side-effects. These respondents believed vaccination offers lifelong protection from contracting Covid-19, weakens symptoms, aids recovery, and prevents transmission. However, it appears that they believed vaccination should be limited at present to those who are at risk (the elderly and people with health problems), that children should not be vaccinated, and that vaccination should be free and compulsory once vaccines have been shown to be safe. This is because they believed that, at present, Covid-19 vaccines are unsafe, not enough is known about them, and vaccinations should wait until experience overseas demonstrates that they work.

Another segment of respondents, the ‘vaccination ambivalent’ (28%), were fundamentally unsure whether vaccination offers protection from contracting Covid-19, weakens symptoms or aids recovery. They were unsure who should be vaccinated and whether vaccination should be compulsory, though they believed it should be free. They were unsure if Covid-19 vaccines are safe or whether vaccinations should wait until experience overseas demonstrates they work.

The fifth segment consisted of the ‘vaccination sceptics’ (8%), who were not convinced vaccinations are beneficial. These respondents did not believe you would recover faster from Covid-19, or have weaker symptoms, if you were vaccinated. They did not believe being vaccinated stops you catching or spreading Covid-19 or gives you lifelong protection. Consequently, they thought vaccinations are a waste of time and effort and should not be compulsory. They believed that children should not be vaccinated, which is consistent with believing that Covid-19 vaccines are unsafe and too little is known about them. They believed vaccinations should wait until experience overseas demonstrates they work.

Vaccine belief segments and being vaccinated

The respondents in the ‘vaccine enthusiasts’ and ‘vaccine moderates’ segments had a strongly favourable attitude towards being vaccinated (Table B4 in S2 Appendix). They were willing to be vaccinated, and as quickly as possible once a vaccine is available (Tables B5 and B6 in S2 Appendix). They were also willing to be vaccinated even if vaccination only offers protection for a few months (Table B7 in S2 Appendix).

When compared to the ‘vaccination enthusiasts’ and the ‘vaccination moderates’, a lower proportion of respondents in the ‘vaccine cautious’ segment had a strongly favourable attitude towards being vaccinated. Those in this segment who did think that being vaccinated is the right thing to do were likely to be vaccinated as quickly as possible once a vaccine (presumably one that is proven to be safe) is available. They were willing to be vaccinated even if vaccination only offers protection for a few months.

Most respondents in the ‘vaccine ambivalent’ segment are unsure about their attitude towards being vaccinated. As a result, they were unsure about being vaccinated, and were less likely to be vaccinated as quickly as possible once a vaccine is available. They were unwilling to be vaccinated if vaccination only offers protection for a few months.

Lastly, the respondents in the ‘vaccine sceptics’ segment had a strongly unfavourable attitude towards being vaccinated. Most were unwilling to be vaccinated, and those in this segment who would consider it would delay being vaccinated once a vaccine was available. They were generally unwilling to be vaccinated if the vaccine only offered protection for a few months.

A relatively high proportion of respondents in the ‘vaccine cautious’ and ‘vaccine sceptics’ segments reported having had a bad experience with vaccinations in the past and knowing someone else who had had a bad experience with vaccinations (Table B8 and B9 in S2 Appendix).

Stage 3: Involvement, beliefs, attitudes, and willingness to be vaccinated

The purpose of this analysis was to quantify the effect of beliefs, attitudes and involvement on respondents’ propensity to be vaccinated for Covid-19. In other words, we wanted to estimate, separately, the influence of involvement (as a measure of the strength of individuals’ motivation) and the influence of beliefs and attitudes on willingness to be vaccinated in the context of Covid-19 in New Zealand.

Following Kaine et al. [13] we hypothesised that:

  • respondents’ attitudes towards eliminating Covid-19 are a function of beliefs about Covid-19 (as these condition the merit of having a policy response to Covid-19), beliefs about the worthiness of eliminating Covid-19 as a policy outcome, and beliefs about Covid-19 vaccinations as a long-term response to Covid-19;

  • respondents’ feelings of responsibility, willingness to change their normal behaviour, work with others and make sacrifices to eliminate Covid-19 are a function of their involvement with, and attitude towards, eliminating Covid-19, and their beliefs about Covid-19;

  • respondents’ attitudes towards being vaccinated for Covid-19 are a function of beliefs about Covid-19 and beliefs about Covid-19 vaccinations;

  • the intensity of respondents’ attitudes towards being vaccinated is a function of involvement with being vaccinated and beliefs about Covid-19;

  • respondents’ involvement with being vaccinated is a function of their involvement with eliminating Covid-19 and their beliefs about Covid-19;

  • the willingness of respondents to act in support of eliminating Covid-19 from New Zealand is a function of involvement with, and attitude towards, being vaccinated (and beliefs about Covid-19);

  • the willingness of respondents to be vaccinated for Covid-19 is a function of involvement with, and attitude towards, being vaccinated (and beliefs about Covid-19).

Respondents’ propensity to be vaccinated was obtained by asking them, ‘Once a vaccine for Covid-19 is available, will you get vaccinated?’ Respondents answered the question using a five-point scale ranging from ‘definitely’ to ‘definitely not’. They were also asked ‘Once a vaccine is available would you get vaccinated as soon as you could?’ and ‘Would you get vaccinated if the vaccine only offered protection for a few months?’ Both questions were answered as ‘yes’, ‘no’ or ‘not sure’, which were coded as binary variables (1 = yes, 2 = no or not sure) for the regression analysis.

Attitude toward eliminating Covid-19 as a strategy was measured as agreement with the statement ‘Eliminating Covid-19 from New Zealand is the right thing to do’ using a five-point scale from ‘strongly disagree’ (1) to ‘strongly agree’ (5). Feelings of responsibility, willingness to change normal behaviour, willingness to work with others, and willingness to make sacrifices to eliminate Covid-19 were measured as agreement with the relevant statement (see Table 11) using a five-point scale from ‘strongly disagree’ (1) to ‘strongly agree’ (5).

Attitude towards being vaccinated was measured by respondents’ average score on the four-item attitudinal scale (see S1 File). Respondents’ agreement with the statements in the attitudinal scale was rated using a five-point scale from ‘strongly disagree’ (1) to ‘strongly agree’ (5). The intensity or strength of attitudes was measured as the absolute value of respondents’ attitude score after subtracting three (3), as this score signified ‘unsure’ in the rating scale for attitudes.

Dummy variables were created representing respondents’ membership of belief segments with respect to Covid-19, eliminating Covid-19, and getting vaccinated. In each instance, the relevant ‘sceptics’ segment was treated as the benchmark.

The explanatory power of the regressions, and the resulting parameter estimates, are reported in Tables 912. The attitudinal regressions were statistically significant and, for cross-sectional data, a substantial proportion of the variance in the attitudes of respondents was explained by their beliefs. In all instances the signs on the estimated parameters were consistent with expectations, with attitudes becoming more and more unfavourable as respondents’ beliefs shifted towards scepticism, as has been found in other studies [6, 8, 44, 45].

Table 9. Estimates of standardised parameters for attitudes towards eliminating Covid-19 and Covid-19 vaccination.

Variable Attitude towards eliminating Covid-19 Attitude towards getting vaccinated
(n = 1002) (n = 1002)
Covid-19 confident 0.118 0.229
(P = 0.138) (P < 0.001)
Covid-19 moderate –0.009 0.186
(P = 0.108) (P < 0.001)
Covid-19 ambivalent –0.196 0.018
(P < 0.001) (P = 0.610)
Covid-19 asymptomatic –0.058 0.090
(P = 0.150) (P < 0.001)
Elimination enthusiast 0.413
(P < 0.001)
Elimination moderate 0.136
(P < 0.001)
Elimination hopeful 0.310
(P < 0.001)
Vaccination enthusiast 0.247 1.107
(P < 0.001) (P < 0.001)
Vaccination moderate 0.205 0.996
(P < 0.001) (P < 0.001)
Vaccination cautious 0.251 0.400
(P < 0.001) (P < 0.001)
Vaccination ambivalent 0.158 0.510
(P = 0.001) (P < 0.001)
Adjusted R2 0.31 0.68
F-test significance <0.001 <0.001

Table 12. Estimates of standardised parameters for involvement with Covid-19 vaccination.

Variable Involvement with getting vaccinated (n = 1002)
Covid-19 confident –0.358 (P < 0.001)
Covid-19 moderate –0.359 (P < 0.001)
Covid-19 ambivalent –0.265 (P < 0.001)
Covid-19 asymptomatic –0.152 (P < 0.001)
Elimination involvement 0.647 (P < 0.001)
Adjusted R2 0.47
F-test significance <0.001

Respondents’ attitude towards eliminating Covid-19 was strongly influenced by beliefs about the effectiveness of an elimination strategy and confidence in vaccination (Table 9). Respondents with ambivalent beliefs about vaccination (the ‘vaccine cautious’) were even more favourably disposed towards elimination than respondents who were more enthusiastic about vaccination, perhaps because elimination might reduce the necessity for vaccination. Beliefs about Covid-19 did not appear to strongly influence attitudes towards elimination over and above beliefs about elimination.

Respondents’ attitude towards being vaccinated for Covid-19 was strongly influenced by beliefs about Covid-19 and beliefs about vaccination (Table 9). Respondents expressed increasingly unfavourable attitudes towards being vaccinated the more sceptical their beliefs about Covid-19 and the more ambivalent their beliefs about vaccination.

The regressions for intensity or strength of attitudes were statistically significant. A reasonable proportion of the variance in attitude strength of respondents was explained by their beliefs about Covid-19, their involvement with eliminating Covid-19, and their involvement with being vaccinated (Table 10). With respect to feelings of responsibility, willingness to change normal behaviour, willingness to work with others, and willingness to make sacrifices to eliminate Covid-19, involvement with, as well as attitude towards, elimination were significant in each regression, as were beliefs about Covid-19 (see Table 11).

Table 10. Estimates of standardised parameters for strength of attitudes towards eliminating Covid-19 and Covid-19 vaccination.

Variable Strength of attitude towards eliminating Covid-19 Strength of attitude towards getting vaccinated
(n = 1002) (n = 1002)
Covid-19 confident 0.286 0.673
(P < 0.001) (P < 0.001)
Covid-19 moderate 0.092 0.434
(P = 0.106) (P < 0.001)
Covid-19 ambivalent 0.009 0.191
(P = 0.846) (P < 0.001)
Covid-19 asymptomatic 0.050 0.237
(P = 0.150) (P < 0.001)
Elimination involvement 0.426
(P < 0.001)
Vaccination involvement 0.250
(P < 0.001)
Adjusted R2 0.29 0.21
F-test significance <0.001 <0.001

Table 11. Estimates of standardised parameters for sense of responsibility, willingness to change behaviour, willingness to make sacrifices, and willingness to work with others to eliminate Covid-19.

Variable I feel some responsibility for eliminating Covid-19 from New Zealand I am prepared to change my normal behaviour to eliminate Covid-19 from New Zealand I am prepared to make sacrifices to eliminate Covid-19 from New Zealand It is important to work together to eliminate Covid-19 from New Zealand
Covid-19 confident 0.050 0.234 0.084 0.351
(P = 0.330) (P < 0.001) (P < 0.001) (P < 0.001)
Covid-19 moderate –0.029 0.142 0.003 0.245
(P = 0.579) (P = 0.002) (P = 0.947) (P < 0.001)
Covid-19 ambivalent –0.100 -0.003 -0.090 0.069
(P = 0.014) (P = 0.924) (P = 0.013) (P = 0.050)
Covid-19 asymptomatic –0.042 0.058 0.039 0.080
(P = 0.176) (P = 0.043) (P = 0.161) (P = 0.013)
Elimination involvement 0.366 0.367 0.379 0.282
(P < 0.001) (P < 0.001) (P < 0.001) (P = 0.003)
Elimination attitude 0.282 0.341 0.353 0.437
(P < 0.001) (P < 0.001) (P < 0.001) (P < 0.001)
Adjusted R2 0.43 0.53 0.54 0.57
F-test significance <0.001 <0.001 <0.001 <0.001

As hypothesised, variations in respondents’ involvement with being vaccinated depended on their involvement with eliminating Covid-19 and their beliefs about Covid-19 (Table 12). While increasing scepticism about Covid-19 was associated with a more unfavourable attitude towards being vaccinated (Table 9), increasing scepticism about Covid-19 was associated with higher involvement with being vaccinated (Table 12). The greater involvement with vaccination associated with increasing scepticism reflects, perhaps, decreasing confidence in the benefits of vaccination, which translates into higher risk and consequence involvement, therefore higher overall involvement with Covid-19 vaccination as scepticism increases. Mean consequence and risk involvement were statistically significantly higher (p < 0.01) for respondents in the ‘covid sceptics’ segment compared to respondents in other segments.

The regressions concerning willingness to be vaccinated were also statistically significant (Table 13). They show that involvement with being vaccinated, in addition to attitude towards being vaccinated, explained a substantial proportion of the variance in respondents’ willingness to be vaccinated. Respondents’ desire to be vaccinated as quickly as possible once vaccines are available depended on their beliefs about Covid-19 as well as their involvement with, and attitude towards, being vaccinated. Similarly, willingness to be vaccinated, even though the effect might be temporary, was influenced by beliefs about Covid-19 as well as involvement with, and attitude towards, being vaccinated.

Table 13. Parameter estimates for willingness to be vaccinated for Covid-19.

Variable Willingness to be vaccinated a Wanting to be vaccinated as quickly as possible b Willing to be vaccinated even if benefits are temporary b
(n = 1002) (n = 874) c (n = 767) d
Covid-19 confident 2.733 2.733
(P<0.001) (P<0.001)
Covid-19 moderate 2.322 2.680
(p<0.001) (p<0.001)
Covid-19 ambivalent 1.856 2.217
(p<0.001) (p<0.001)
Covid-19 asymptomatic 1.810 1.810
(P = 0.010) (P = 0.006)
Involvement with being vaccinated 0.142 0.534 0.579
(p<0.001) (p = 0.010) (p = 0.003)
Attitude towards being vaccinated 0.749 2.120 1.415
(p<0.001) (p<0.001) (p<0.001)
Intercept -16.298 -14.762
(p<0.001) (p<0.001)
Adjusted R2 0.70 0.44e 0.29e
F-test significance <0.001 <0.01 <0.01

Notes: Involvement scored as a rating from 1 to 5 (low to high involvement).

Attitude scored as a rating from 1 to 5 (unfavourable to favourable).

Willingness to be vaccinated scored as a rating from 1 to 5 (always to never).

Willing to be vaccinated as quickly as possible scored as a binary (1 = yes, 0 = no or not sure).

Willing to be vaccinated even if protection is temporary scored as a binary (1 = yes, 0 = no or not sure).

a Standardised parameter estimates reported for willingness to be vaccinated.

b Estimated as binary logistic regressions.

c Respondents who indicated they probably or definitely would not get vaccinated did not answer this question

d Respondents who indicated they probably or definitely would not get vaccinated, or who indicated they would delay getting vaccinated, did not answer this question.

e Nagelkerke R-Square.

Discussion

Our results clearly indicate that involvement with eliminating Covid-19, as well as beliefs about Covid-19, significantly influence feelings of responsibility, willingness to change normal behaviour, willingness to work with others, and willingness to make sacrifices to eliminate Covid-19. Our results show that involvement, a measure of motivational strength, contributes significantly to predictions of people’s willingness to be vaccinated as well as their attitude towards being vaccinated. Also, our results show that involvement contributes significantly to predictions of the strength of people’s attitude towards being vaccinated. The simple but important conclusion that follows from these results is that people may hold similar opinions or attitudes towards a protocol such as being vaccinated, but their propensity to do so may vary markedly depending on how involved they are with–how strongly they care about–preventing the spread of Covid-19 and getting vaccinated.

This conclusion has important implications for promoting community participation in mass vaccination programmes for Covid-19 to overcome the five components of vaccine hesitancy: confidence, complacency, constraints, calculation, and collective responsibility [6]. The first is related to the possibility that people may fail to comply with a measure even though they may have favourable attitudes towards the policy outcome, simply because they are not paying attention. In circumstances where involvement is low, compliance (or non-compliance) is not a matter of deliberate choice. This means that people who have low involvement with eliminating Covid-19 and with being vaccinated (quadrant 1) may fail to be vaccinated simply because it is inconvenient, not because they may have an unfavourable attitude towards being vaccinated. In terms of the 5C model, they are constrained.

Maximising vaccinations among people with low involvement requires ensuring that getting vaccinated requires as little effort and thought as is practical, and the experience is as stress-free as possible [46]. This means offering vaccinations at as many sites as possible, and at venues that are routinely visited such as shopping malls, churches, fast food outlets, workplaces, and sporting facilities. The aim is to minimise time spent travelling and queuing, and to create opportunities to be vaccinated on impulse. People with low involvement are likely to respond favourably to relatively small financial incentives if the process of being vaccinated is convenient and quick.

Relatedly, authorities should carefully consider the imposition of blanket penalties for non-compliance because they run the risk of incidentally alienating people with low involvement. For example, mandating workplace vaccinations for Covid-19 or the wearing of full personal protection equipment (PPE) by the unvaccinated may generate resentment, and possibly resistance, among those with low involvement (quadrant 1) irrespective of their attitude, albeit weak, towards Covid-19. Ensuring vaccinations can be obtained quickly and conveniently would be essential to alleviating feelings of resentment among those with low involvement.

In circumstances where involvement is high, compliance (or non-compliance) is most likely to be a deliberate choice, depending on one’s attitude. With respect to being vaccinated for Covid-19, if attitudes towards vaccination are strongly unfavourable, then severe penalties or substantial inducements may be required to secure compliance. For example, in the workplace this may mean compelling staff either to be vaccinated or to wear full PPE and submit to a rigorous testing regime; and similarly, requiring international travellers to self-isolate in quarantine for a lengthy period (at their cost) if they are unvaccinated.

In relation to people with an unfavourable attitude towards being vaccinated, it is important to distinguish people who have high involvement with being vaccinated and with eliminating Covid-19 (quadrant 3) from people who have high involvement with being vaccinated but low involvement with eliminating Covid-19 (quadrant 4). In terms of the 5C model, the former (quadrant 3) may be encouraged to seek vaccination using promotional messages aimed at reducing their complacency, building their confidence in Covid-19 vaccines, and appealing to their sense of collective responsibility. The latter (quadrant 4) are unlikely to respond favourably to such promotional messages because they have little interest in preventing the spread of Covid-19. Consequently, they are unlikely to respond to an appeal to their sense of collective responsibility.

Theoretically, people who have high involvement with being vaccinated but low involvement with eliminating Covid-19, and an unfavourable attitude towards being vaccinated (quadrant 4), are likely to be most confrontational in their opposition to being vaccinated. As they have little, if any, interest in the policy outcome of eliminating Covid-19, there is no justification, in their view, for forcing them to be vaccinated. Clearly, differences in the level of involvement people have with the outcome of eliminating Covid-19 and with being vaccinated to prevent the spread of Covid-19 create an additional complication for authorities.

Another implication concerns the possibility that people who have low involvement with the policy outcome and the policy measures may miss important promotional messages simply because they are not paying attention. In circumstances where involvement with a subject is low, exposure and sensitivity to promotional messages about the subject is low. Messages are not necessarily deliberately ignored; they simply fail to catch the attention of those with low involvement (they are just not noticed). This means, in circumstances where involvement is low, promotional efforts intended to increase the rate of vaccinations are unlikely to succeed because these efforts will, largely, be ignored. The lack of interest in eliminating Covid-19 and in being vaccinated (quadrant 1) means those with low-to-mild involvement will, from a 5C model perspective, not be attentive to promotional messages intended to build their confidence in vaccines, lessen their complacency, encourage them to greater calculation, or engender a sense of collective responsibility.

The attention of people with low involvement in a subject can be captured if messages about the subject can be linked to another matter that is involving for them. This requires identifying, for those not interested in Covid-19, themes that are involving for them and that can be meaningfully linked to containing the spread of Covid-19. Examples include framing messages about being vaccinated for Covid-19 in the context of protecting families and jobs, avoiding lockdowns, and being able to travel freely overseas [43].

A further implication concerns the intrinsic malleability of the beliefs and attitudes of people who have low involvement with a subject. Such people devote little time and effort to gathering information about the subject, evaluating that information, and forming beliefs about and attitudes towards the subject. Their search for information (calculation in the 5C model) is particularly limited. This means their beliefs and attitudes may be unstable and can change rapidly.

With respect to preventing the spread of Covid-19, this raises the possibility that, on the one hand, the distribution of misinformation about Covid-19 vaccinations through social media may provoke changes in the beliefs and attitudes of people with low involvement in Covid-19 that are undesirable because they undermine willingness to be vaccinated [12, 44, 47]. Such misinformation may provide a self-serving rationale for failing to seek vaccination should that require an investment of time and effort. On the other hand, people with low involvement are unlikely to strongly endorse misinformation (unless it is framed within a context they find highly involving) and so are unlikely to be provoked into engaging in non-compliant behaviours that require an investment of time and effort (such as attending protest rallies). However, in the context of vaccinating for infectious diseases like Covid-19, even inaction (failing to be vaccinated) can be damaging to the community.

The last implication we will consider concerns the intrinsic fixedness of the attitudes of people who have high involvement with a subject once their attitudes are established. In principle, these people have devoted substantial time and effort to gathering information about the subject, evaluating that information, and then forming beliefs about and, subsequently, formulating an attitude towards the subject. In other words, they have engaged in an extensive search for information. Consequently, their attitudes are stable and resistant to change. These people may well engage in motivated reasoning [1012]. Hence, those who have high involvement with, and a favourable attitude towards, being vaccinated will resist misinformation about Covid-19. Those who have high involvement with, but an unfavourable attitude towards, being vaccinated will be more likely to embrace misinformation.

People with high involvement who are ambivalent about vaccination may be influenced by misinformation. However, these people are not uninformed. From a 5C model perspective, their ambivalence is likely to be a product of tension between the threat of infection (complacency) and fears about the safety of vaccines (confidence). Consequently, they will probably be responsive to promotional messages reminding them of the dangers posed by Covid-19 (complacency) while reassuring them about the safety of vaccines (confidence) and appealing to their sense of collective responsibility. The emergence of more dangerous variants of Covid-19 such as delta is likely to increase the receptivity of people in this quadrant to messaging and diminish their hesitancy [48]. These considerations suggest that government authorities must be careful to discriminate between audiences on social media in terms of involvement when it comes to investing resources in combating misinformation about Covid-19.

The willingness of people to adopt behaviours such as being vaccinated for infectious diseases like Covid-19 has been the subject of numerous studies [14, 68]. These studies have shown that willingness to be vaccinated does depend on people’s attitudes, which in turn depend on their beliefs about the advantages and disadvantages of vaccinations. Consequently, many of these studies recommend that the adoption of preventive behaviours can be improved through promotional efforts intended to change beliefs and attitudes. Our results have two important implications for such recommendations.

First, while it is undoubtedly true that changing attitudes can change behaviour, promotional efforts intended to change beliefs and attitudes about vaccination are unlikely to meet with complete success unless most people have moderate-to-high involvement both with preventing the spread of Covid-19 and with being vaccinated. Fortunately, this is the case in New Zealand.

Second, the greater the proportion of people with low-to-mild involvement with preventing the spread of Covid-19 and with getting vaccinated, the more likely will efforts to improve the ease and convenience of getting vaccinated be effective in changing behaviour compared to promotional efforts aimed at doing so by changing people’s beliefs and attitudes.

Our findings are subject to several qualifications. First, beliefs, attitudes and behaviours regarding preventing the spread of Covid-19 and getting vaccinated for Covid-19 may have changed over time with the emergence of the delta and omicron variants as the pandemic has progressed. Second, the survey sample was drawn from an internet panel, so there may be selection bias. While the nature and severity of this bias in relation to the beliefs, attitudes and involvement we investigated is unknown, it does seem reasonable to suppose, ceteris paribus, that people with low-to-mild involvement may be under-represented in the sample. If so, this would reinforce the importance of our cautions with respect to choosing actions to increase the uptake of vaccination.

Third, as the scales measuring willingness to be vaccinated for Covid-19 were self-reported, our measurements may have been affected by social desirability bias [49]. Public awareness of the widely promoted social desirability of getting vaccinated for Covid-19 creates the possibility that self-reported behaviour regarding willingness to be vaccinated may be biased simply because it is socially desirable. Daoust et al. [49] found that this was the case with respect to self-reported behaviour such as mask wearing and social distancing in the context of Covid-19. However, the degree of bias with respect to vaccine hesitancy is likely to be small given that vaccination hesitancy is a widespread phenomenon, which implies hesitancy has a degree of social acceptability. The rate at which the acceptability of vaccine hesitancy has diminished recently, in nations like Australia, for example, also suggests that it is not regarded as an extreme, albeit starting, attitude to adopt [48].

The potential for systematic bias in self-reporting of socially desirable behaviours (or opinions) in the context of the I3 Framework is unclear. On the one hand, those with low involvement in, say, eliminating Covid-19 and getting vaccinated might be expected to exhibit (downward) social desirability bias in self-reporting this behaviour because they are less motivated to actually engage in the behaviour. However, their very lack of interest means they may be quite insensitive to the opinions of others about the behaviour and so are less susceptible to social desirability bias.

On the other hand, those with high involvement in eliminating Covid-19 and getting vaccinated might be expected to exhibit (upward or downward) social desirability bias in self-reporting behaviours, depending on their attitude, because they are motivated to actually engage in the behaviour. Their strong interest may mean they are quite sensitive to the opinions of others about the behaviour (especially if expressing self-identity is an important source of involvement), so they may be more susceptible to social desirability bias. Through this argument, self-reporting of socially desirable behaviours like getting vaccinated might mean the actual association between involvement and engagement in such behaviours could be over-estimated or under-estimated. Clearly, the interaction between involvement and social desirability bias remains an important area for further investigation.

Overall, the degree of bias in self-reporting is likely to be small given that vaccination hesitancy is a widespread phenomenon, which implies it has a degree of social acceptability. Also, the deliberate, non-leading design of our questionnaire, by offering various degrees of compliance with relevant social norms, may be less likely to trigger guilt about breaching them. (Further work will clarify the impact of the bias on the I3 Framework).

Fourth, the adoption of behaviours such as being vaccinated has been associated with a range of variables, including those relating to complacency, such as the perceived risk of infection, the local incidence rate of Covid-19, and feelings of stress in relation to Covid-19 (see [46] for example). We did not include these variables in our analysis, and, while the correlation between these variables and involvement is unknown, it is likely to be positive.

Conclusions

Governments around the world are seeking to slow the spread of Covid-19 by implementing mass vaccination programmes. The success of these programmes depends on the commitment of individuals to respond and participate. Hence, understanding and predicting the motivation of individuals to participate is critical for designing measures to maximise participation and ensure the effectiveness of these measures in slowing the spread of the virus.

Kaine et al. [13] hypothesised that the propensity of individuals to change their behaviour and comply with policy measures depends on the intensity of their involvement with, and their attitude towards, the measure. This is because cognitive effort is required to form a strongly held attitude, and such effort is only invested when the matter at hand is sufficiently important to the individual. They also hypothesised that the propensity of individuals to comply with policy measures also depends on their involvement with the policy outcome the measure addresses. An implication of these hypotheses is that individuals with similar attitudes will display varying degrees of compliance with policy measures depending on the intensity of their involvement with the policy outcome and the policy measure.

We tested these hypotheses, and their implications, with respect to public willingness to be vaccinated to prevent the spread of Covid-19 in New Zealand. Broadly speaking, the hypotheses and their implications were supported by the results. The finding that willingness to be vaccinated depends on involvement (motivation) as well as attitude has important implications for the design of policy measures intended to promote high vaccination rates. This finding also has important implications for the design of promotional programmes intended to encourage the participation of the community in mass vaccination programmes.

With respect to preventing the spread of Covid-19 in New Zealand, the results highlight the importance of distinguishing between those with a lack of interest in getting vaccinated from those who strongly oppose vaccination, and therefore deliberately choose not to be vaccinated, and tailoring incentive and enforcement strategies appropriately. The results also highlight the difficulty of communicating effectively through mass media with those who have low involvement with preventing the spread of Covid-19, and the importance of distinguishing between those with low and high involvement in considering the possible effects on vaccination beliefs, and vaccination rates, of the dissemination of misinformation about Covid-19 through social media.

Supporting information

S1 File. Questionnaire.

(DOCX)

S2 File. Data.

(XLSX)

S1 Appendix

(PDF)

S2 Appendix

(PDF)

Acknowledgments

We would sincerely like to thank the panellists throughout New Zealand who completed the questionnaire. Thanks also to our two anonymous referees for their constructive advice and suggestions.

Data Availability

All relevant data are within the manuscript and its Supporting information files.

Funding Statement

This research was funded by the New Zealand Ministry for Business, Innovation and Employment (https://www.mbie.govt.nz/) through the Te Pūnaha Matatini – NZ COVID Modelling Programme (https://www.tepunahamatatini.ac.nz/). MWLR Client project number: UOAX1941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014; 32(19): 2150–2159. doi: 10.1016/j.vaccine.2014.01.081 [DOI] [PubMed] [Google Scholar]
  • 2.Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: a critical review. Social Science & Medicine. 2014; 112: 1–11. doi: 10.1016/j.socscimed.2014.04.018 [DOI] [PubMed] [Google Scholar]
  • 3.Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HJ. Strategies for addressing vaccine hesitancy: a systematic review. Vaccine. 2015; 33(34): 4180–4190. doi: 10.1016/j.vaccine.2015.04.040 [DOI] [PubMed] [Google Scholar]
  • 4.Dyda A, King C, Dey A, Leask J, Dunn AG. A systematic review of studies that measure parental vaccine attitudes and beliefs in childhood vaccination. BMC Public Health 2020; 20: 1253. doi: 10.1186/s12889-020-09327-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE. 2018; 13(12): e0208601. doi: 10.1371/journal.pone.0208601 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wismans A, Thurik R, Baptista R, Dejardin M, Janssen F, Franken I. Psychological characteristics and the mediating role of the 5C Model in explaining students’ COVID-19 vaccination intention. PLoS ONE. 2021; 16(8): e0255382. doi: 10.1371/journal.pone.0255382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, et al. Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines (Basel). 2020; 8(4): 582. doi: 10.3390/vaccines8040582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychological Medicine. 2021; 1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Huynh HP, Senger AR. A little shot of humility: intellectual humility predicts vaccination attitudes and intention to vaccinate against COVID-19. J Appl Soc Psychol. 2021; 51: 449–460. doi: 10.1111/jasp.12747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kunda Z. The case for motivated reasoning. Psychological Bulletin. 1990; 108(3): 480–498. doi: 10.1037/0033-2909.108.3.480 [DOI] [PubMed] [Google Scholar]
  • 11.Hornsey MJ, Harris EA, Fielding KS. The psychological roots of anti-vaccination attitudes: a 24-nation investigation. Health Psychol. 2018; 37(4): 307–315. doi: 10.1037/hea0000586 Epub 2018 Feb 1. [DOI] [PubMed] [Google Scholar]
  • 12.Stasiuk K, Maciuszek J, Polak M, Doliński D. Profiles of vaccine hesitancy: the relation between personal experience with vaccines, attitude towards mandatory vaccination, and support for anti-vaccine arguments among vaccine hesitant individuals. Social Psychological Bulletin. 2012; 16(2): 1–20. doi: 10.32872/spb.6525 [DOI] [Google Scholar]
  • 13.Kaine G, Murdoch H, Lourey R, Bewsell D. A framework for understanding individual response to regulation. Food Policy. 2010; 35: 531–537. [Google Scholar]
  • 14.Kim Y. Conceptualizing health campaign strategies through the level of involvement. Corp Commun Int J. 2003; 8: 255–267. [Google Scholar]
  • 15.Zaichkowsky JL, Measuring the involvement construct. J Consum Res. 1985; 12: 341–352. [Google Scholar]
  • 16.Ajzen I, Fishbein M. Attitude-behaviour relations: a theoretical analysis and review of empirical research. Psychol Bull. 1977; 84: 888–918. [Google Scholar]
  • 17.Kassarjian HH. Low involvement: a second look. In: Monroe KB, editor. Advances in Consumer Research: Association for Consumer Research; 1981. pp. 31–34. [Google Scholar]
  • 18.Chaffee SH, Roser C. Involvement and the consistency of knowledge, attitudes, and behaviours. Commun Res. 1986; 13: 373–399. [Google Scholar]
  • 19.Murdoch H, Bewsell D, Lourey R, Kaine G. Understanding people’s response to biosecurity regulation. Decision Making in Uncertain Times, 3rd National Conference on Risk Management. The New Zealand Society for Risk Management Inc, Auckland, 2006.
  • 20.Petty RE, Cacioppo JT. The effects of involvement on responses to argument quantity and quality: central and peripheral routes to persuasion. J Pers Soc Psychol. 1984; 46: 69–81. [Google Scholar]
  • 21.Thaler R.H, Sunstein CR. Nudge: Improving decisions about health, wealth, and happiness. New Haven, CT: Yale University Press; 2008. [Google Scholar]
  • 22.Gunningham N, Grabosky P, Sinclair D. Smart regulation: Designing environmental policy. New York: Oxford University Press; 1998. [Google Scholar]
  • 23.Davies A, Kaine G, Lourey R. Understanding factors leading to non-compliance with effluent regulations by dairy farmers. Environment Waikato Technical Report 2007/37. Hamilton: Environment Waikato; 2007.
  • 24.Carlough L. General deterrence of environmental violation: a peek into the mind of the regulated public. Oregon Department of Environmental Quality; 2003. http://www.deq.state.or.us/programs/enforcement.
  • 25.Kaine G, Tostovrsnik N. Landholders and the management of weeds: Blackberry and serrated tussock. Service Design Research Working Paper 03–11. Tatura, Victoria: Department of Primary Industries; 2011.
  • 26.Lourey R, Kaine G, Davies A, Young J. Landholder responses to incentives for wild dog control. Service Design Research Working Paper 07–11. Tatura, Victoria: Department of Primary Industries; 2011.
  • 27.Kaine G. An application of the I3 framework to rat control in Hawke’s Bay. Manaaki Whenua–Landcare Research Contract Report LC3646; Hamilton, New Zealand: 2019.
  • 28.Kaine G, Kirk N, Kannemeyer R, Stronge D, Wiercinski B. Predicting people’s motivation to engage in urban possum control. Conservation. 2021; 1: 196–215. doi: 10.3390/conservation1030016 [DOI] [Google Scholar]
  • 29.Kaine G, Stronge D. An application of the I3 framework to rat control in New Plymouth. Manaaki Whenua–Landcare Research Contract Report LC3734; Hamilton, New Zealand: 2020.
  • 30.Kaine G, Kannemeyer R, Stronge D. Using 1080 to control possums and rats: an application of the I3 framework. Manaaki Whenua–Landcare Research Contract Report LC3747; Hamilton, New Zealand: 2020.
  • 31.New Zealand Government. History of the COVID-19 alert system; 2021. https://covid19.govt.nz/alert-system/history-of-the-covid-19-alert-system/
  • 32.Travica B. Containment strategies for COVID-19 pandemic; 2020. https://ssrn.com/abstract=3604519 or 10.2139/ssrn.3604519 [DOI]
  • 33.Ministry of Health. COVID-19: Elimination strategy for Aotearoa New Zealand; 2021. https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-response-planning/covid-19-elimination-strategy-aotearoa-new-zealand
  • 34.Ministry of Health, COVID-19 Vaccine data, (2020). https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-data-and-statistics/covid-19-vaccine-data
  • 35.Laurent G, Kapferer J.-N. Measuring consumer involvement profiles. J Mark Res. 1985; 22: 41–53. [Google Scholar]
  • 36.Kaine G. A pilot application of the I3 framework to compliance behaviour in farming. Manaaki Whenua–Landcare Research Contract Report LC3513; Hamilton, New Zealand: 2019.
  • 37.Olsen SO. Strength and conflicting valence in measurement of food attitudes and preferences. Food Quality and Preferences. 1999; 10: 483–494. [Google Scholar]
  • 38.Carmines EG, Zeller RA. Reliability and validity assessment. Newbury Park, CA: Sage; 1979. [Google Scholar]
  • 39.Aldenderfer MS, Blashfield RK. Cluster analysis. Newbury Park, California: Sage; 1984. [Google Scholar]
  • 40.Tukey J. Comparing individual means in the analysis of variance. Biometrics. 1949; 5(2): 99–114. doi: 10.2307/3001913 [DOI] [PubMed] [Google Scholar]
  • 41.IBM Corp. IBM SPSS Statistics for Windows, Version 27.0. 2020. Armonk, NY: IBM Corporation.
  • 42.Kaine G, Wright V. Involvement and willingness to be vaccinated against Covid-19. Manaaki Whenua–Landcare Research Contract Report LC3958; Hamilton, New Zealand: 2021.
  • 43.Wilson S. Pandemic leadership: lessons from New Zealand’s approach to COVID-19. Leadership. 2020; 16: 279–293. doi: 10.1177/1742715020929151 [DOI] [Google Scholar]
  • 44.Allington D, Duffy B, Wessely S, Dhavan N, Rubin J. Health-protective behaviour, social media usage, and conspiracy belief during the COVID-19 public health emergency. Psychological Medicine. 2020. doi: 10.1017/S003329172000224X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Imhoff R, Lamberty P. A bioweapon or a hoax? The link between distinct conspiracy beliefs about the Coronavirus disease (COVID-19) outbreak and pandemic behaviour; 2020. doi: 10.1177/1948550620934692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Lieberoth A, Lin S-Y, Stöckli S, Han H, Kowal M, Gelpi R, et al. Stress and worry in the 2020 coronavirus pandemic: relationships to trust and compliance with preventive measures across 48 countries in the COVIDiSTRESS global survey, 2021, R Soc Open Sci. 2021; 8200589200589. doi: 10.1098/rsos.200589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Bridgman A, Merkley E, Loewen PJ, Owen T, Ruths D, Teichmann L, et al. The causes and consequences of COVID-19 misperceptions: understanding the role of news and social media. The Harvard Kennedy School (HKS) Misinformation Review. 2020; 1: Special Issue on COVID-19 and Misinformation.
  • 48.Melbourne Institute. Vaccine Hesitancy Tracker (2020). https://melbourneinstitute.unimelb.edu.au/publications/research-insights/ttpn/vaccination-report.
  • 49.Daoust JF, Bélanger É, Dassonneville R, Lachapelle E, Nadeau R, Becher M, et al. A guilt-free strategy increases self-reported noncompliance with COVID-19 preventive measures: experimental evidence from 12 countries. PLoS ONE. 2021; 16(4): e0249914. doi: 10.1371/journal.pone.0249914 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Camelia Delcea

21 Dec 2021

PONE-D-21-33647Predicting willingness to be vaccinated for Covid-19: evidence from New ZealandPLOS ONE

Dear Dr. Kaine,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Specifically, in the revised version of the paper please better describe the framework used and the conducted analysis.The writing flow in some key parts of the paper - quality of the analysis and concluding remarks - is very difficult to follow. When submitting the revised version of the paper, please consider the reviewers' comments.

Please submit your revised manuscript by Jan 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Camelia Delcea

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: I Don't Know

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Key elements such as appropriate references, or figures and tables are missing

The quality of the language is not sufficient for review to take place

Tables and figures are not clear enough to read

The paper doesn’t conform to the journal’s Author Guidelines

The presentation of the paper is very poor

Reviewer #2: Review for PONE-D-21-33647

The study explores people’s attitudes towards the COVID-19 vaccine in New Zealand using a relatively new motivational framework, the I3. While I think the study has potential, it was a little difficult to follow. Therefore, I believe some revisions are required before publishing the paper.

Specific comments

1. I found the discussion of the I3 framework a little difficult to follow until I got to Figure 1 and the examples in the context of vaccine hesitancy. Perhaps the authors could provide the example of vaccine hesitancy together with their explanation rather than after it. Alternatively, they can provide a briefer general explanation and then give examples sooner.

2. The authors transition from discussing their framework to COVID-19 in New Zealand to the methods section. Since the paragraph explaining the study itself is on page 4, nine pages earlier, the reader may forget the purpose of the study. I suggest adding a short paragraph explaining what was done and why before turning to the methods section.

3. The paragraph on instrumentation was a little confusing. The authors say that there was a scale measuring involvement, but then that the order of the involvement, attitude, and belief scales was randomized. How were attitudes and belief measured? Then, the authors discuss how the attitudes scores were calculated but I could not find the scales used. It would be easier to follow if the authors had a separate paragraph for each measure and the traditional sections for instrumentation, sample, procedure, etc., though the methods section could be made clearer without using this format.

4. The authors provided information on the status of COVID-19 measures in New Zealand at the time of data collection, which is important. What was the vaccination status at the time? Were vaccines available at the time?

5. The authors wrote several paragraphs about self-report bias in the methods section. While this presents an interesting question, usually it belongs in the discussion section. Moving these paragraphs to the discussion will again make the manuscript clearer.

6. I did not understand how the respondents were classified into belief segments. Ward’s method implies a cluster analysis was used, is that so? Was this method used in other contexts using this scale, and were any validation measures used? This seems to be the main finding of the study and the results describe the clustering, so it should be presented in more detail.

7. I suggest adding standard deviations to the tables when relevant.

8. The belief segments section explains why the study was conducted and the analytic approach. I think these should be in the introduction and methods section, respectively, as exploring the belief segments is a part of the study, again adding the aforementioned details about the cluster analysis. Alternatively, the authors may split the results into “study 1” and “study 2” if they feel like the studies are separate. There are similar problems in other parts of the results section.

9. I suggest reporting the standardized coefficients in the regression tables to facilitate interpretability.

Minor comments

1. On page 4, I find it odd that the authors discuss the results before presenting them. I think the authors should discuss the framework and its importance, not specific results.

2. Figure 1 should be of higher quality.

Reviewer #3: Please put more specific information on the use of each statistical test/method used in the analysis in the Materials and Methods section, such as the use of Chronbach's Alpha (page 19, line 429), Chi-Square test (pages 19-20, 22, lines 436, 441, 448, 457, 496-498), Tukey's HSD test (pages 22, 23, lines 488, 495), Binary Logistic Regression (page 38, lines 746, 747, 748), Nagelkerke R Square (page 38, line 753), to give some knowledge to the audience/readers so that your research may be more reproducible.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Apr 7;17(4):e0266485. doi: 10.1371/journal.pone.0266485.r002

Author response to Decision Letter 0


13 Jan 2022

Dear Editor,

Thank you for providing us with the opportunity to revise and resubmit our manuscript. I have entered a revised manuscript with and without ‘track’ changes as requested.

You raised the following you wished us to address:

• Specifically, in the revised version of the paper please better describe the framework used and the conducted analysis. The writing flow in some key parts of the paper - quality of the analysis and concluding remarks - is very difficult to follow. When submitting the revised version of the paper, please consider the reviewers' comments.

We have revised the manuscript in accord with reviewers’ comments, focussing in particular on the methods and results sections. Our revisions to the reviewers’ comments are described in detail below.

Please do not hesitate to contact us if there is anything else you require.

Kind regards

Dr Geoff Kaine. 

Reviewer #2 comments:

1. I found the discussion of the I3 framework a little difficult to follow until I got to Figure 1 and the examples in the context of vaccine hesitancy. Perhaps the authors could provide the example of vaccine hesitancy together with their explanation rather than after it. Alternatively, they can provide a briefer general explanation and then give examples sooner.

We had provided examples with respect to vaccine hesitancy in the Theory section where we introduce the I3 model. We have made the link between vaccine hesitancy and the I3 model clearer by referring specifically to the 5C model in that section. See revised lines 95, 100, 191, 213 and 268 (in the manuscript with track changes).

2. The authors transition from discussing their framework to COVID-19 in New Zealand to the methods section. Since the paragraph explaining the study itself is on page 4, nine pages earlier, the reader may forget the purpose of the study. I suggest adding a short paragraph explaining what was done and why before turning to the methods section.

We have added a short paragraph at the commencement of the Methods sections describing the purpose of the study as suggested (lines 308-312 in the manuscript with track changes). We have also added a description of the steps in the analysis, and the purpose of each step, to the Methods section (lines 432-463 in the manuscript with track changes).

3. The paragraph on instrumentation was a little confusing. The authors say that there was a scale measuring involvement, but then that the order of the involvement, attitude, and belief scales was randomized. How were attitudes and belief measured? Then, the authors discuss how the attitudes scores were calculated but I could not find the scales used. It would be easier to follow if the authors had a separate paragraph for each measure and the traditional sections for instrumentation, sample, procedure, etc., though the methods section could be made clearer without using this format.

We have added additional material to the Methods section to provide more clarity on measurement methods (lines 320-324, 329-349 in the manuscript with track changes).

4. The authors provided information on the status of COVID-19 measures in New Zealand at the time of data collection, which is important. What was the vaccination status at the time? Were vaccines available at the time?

We have revised the relevant paragraph (lines 300-305 in manuscript with track changes) to be clear the study was conducted before vaccines were made available to the general public in New Zealand.

5. The authors wrote several paragraphs about self-report bias in the methods section. While this presents an interesting question, usually it belongs in the discussion section. Moving these paragraphs to the discussion will again make the manuscript clearer.

We have shifted the relevant paragraphs to the Discussion section (lines 998-1036 in the manuscript with track changes).

6. I did not understand how the respondents were classified into belief segments. Ward’s method implies a cluster analysis was used, is that so? Was this method used in other contexts using this scale, and were any validation measures used? This seems to be the main finding of the study and the results describe the clustering, so it should be presented in more detail.

We have revised the Methods section (lines 441-450 in the manuscript with track changes) and the reporting of the belief segments results to make it clear that cluster analysis was employed (lines 583, 594, 609, 621 in the manuscript with track changes). We have also added material to the Methods section to explain the steps in the analysis (lines 432-463 in the manuscript with track changes) and to clarify the purpose of the belief segment analysis was simply to condense the belief data into a smaller set of dummy variables for use in the regression analyses. This clarifies that the main finding of the study concern the regression results (and not the belief segment results).

7. I suggest adding standard deviations to the tables when relevant.

In our opinion adding standard deviations to the tables is unnecessary as we already report significance test results in all the relevant tables (which are themselves based on standard deviations), thereby saving the reader the effort of interpreting the results themselves.

8. The belief segments section explains why the study was conducted and the analytic approach. I think these should be in the introduction and methods section, respectively, as exploring the belief segments is a part of the study, again adding the aforementioned details about the cluster analysis. Alternatively, the authors may split the results into “study 1” and “study 2” if they feel like the studies are separate. There are similar problems in other parts of the results section.

We have added material to the Methods section to explain the steps in the analysis (lines 432-463 in the manuscript with track changes) and to clarify the purpose of the belief segment analysis was to condense the belief data into a smaller set of dummy variables for use in the regression analyses. Hence splitting the results into separate studies was not appropriate. We have revised the opening paragraphs of the belief segments section accordingly (lines 574-581 in the manuscript with track changes).

9. I suggest reporting the standardized coefficients in the regression tables to facilitate interpretability.

We have revised the relevant tables to report standardised regression coefficients for OLS regressions (Tables 9-13).

Minor comments

1. On page 4, I find it odd that the authors discuss the results before presenting them. I think the authors should discuss the framework and its importance, not specific results.

We have removed the two paragraphs describing the results from the Introduction (lines 73-91 in the manuscript with track changes).

2. Figure 1 should be of higher quality.

We have revised the Figure.

Reviewer #3 comments:

Please put more specific information on the use of each statistical test/method used in the analysis in the Materials and Methods section, such as the use of Cronbach's Alpha (page 19, line 429), Chi-Square test (pages 19-20, 22, lines 436, 441, 448, 457, 496-498), Tukey's HSD test (pages 22, 23, lines 488, 495), Binary Logistic Regression (page 38, lines 746, 747, 748), Nagelkerke R Square (page 38, line 753), to give some knowledge to the audience/readers so that your research may be more reproducible.

We have indicated where we have used these tests and methods in the additional material in the Methods section (lines 432-463 in the manuscript with track changes).

Attachment

Submitted filename: Response to reviewers january.docx

Decision Letter 1

Camelia Delcea

18 Feb 2022

PONE-D-21-33647R1Predicting willingness to be vaccinated for Covid-19: evidence from New ZealandPLOS ONE

Dear Dr. Kaine,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for the revised version of the paper. Please consider the reviewer comments when re-submitting the paper.

Please note that reviewer 1 has requested citations which have limited relevance to the study topic. As such we suggest that you carefully review whether the suggested references further contribute to the literature discussion of your study. Please feel free to ignore any referenced without direct relevance.<o:p></o:p>

Please submit your revised manuscript by Apr 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Lucinda Shen 

Staff Editor 

on behalf of 

Camelia Delcea

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

********** 

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Kindly, cite these references related to microorganism propulsion mechanism:

1. Dynamical interaction effects on soft-bodied organisms in a multi-sinusoidal passage. Eur. Phys. J. Plus, 136 (6) (2021), 1-17

2. , Locomotion of an efficient biomechanical sperm through viscoelastic medium. Biomech. Model Mechanobiol., 19 (2020), 2271-2284

3. An implicit finite difference analysis of magnetic swimmers propelling through non-Newtonian liquid in a complex wavy channel, Comput. Math. Appl., 79 (8) (2020) 2189-2202

4. Analytical and numerical study of creeping flow generated by active spermatozoa bounded within a declined passive tract. Eur. phys. j. plus, 134 (2019) 9

5. a mathematical model of the locomotion of bacteria near an inclined solid substrate: effects of different waveforms and rheological properties of couple stress slime. Can. J. Phys., 97 (2019) 537-547.

6. Magnetic microswimmers propelling through biorheological liquid bounded within an active channel. J. Magn. Magn. Mater., 486 (2019) 165283.

7. A hybrid numerical study of bacteria gliding on a shear rate-dependent slime. Physica A: Stat. Mech. Appl.. 535 (2019) 122435.

Reviewer #2: Review for PONE-D-21-33647-R1

I would like to thank the authors for their extensive work on this manuscript. It is now much clearer, and therefore I am able to provide more specific feedback. Overall, this study is interesting and valuable. I believe some clarifications are needed, and will greatly improve the manuscript.

Specific comments

1. The paper still suffers from minor organization issues. For example, the authors introduce the 5C framework but then say that the study uses the I3 framework, without explaining what it is and how they are connected until much later, or discuss the 5C model among people in quadrant 3 with unfavorable attitudes towards the measure before discussing those attitudes.

2. The way I understand Kaine et al. (2010), involvement with the issue in this context does not necessarily mean wanting to prevent the spread of COVID, but rather interest and research on the topic and involvement in decision-making related to it. One might conduct their own research and deduce that COVID is not very dangerous, an option addressed in the scales used in this study. This places them in the third quadrant (with unfavorable views), however, the description of this quadrant does not fit them. Could the authors please clarify the meaning of involvement with the issue, and if I understood correctly, adjust the quadrants’ descriptions accordingly?

3. On page 7 line 158: “because people in this quadrant are uninterested, they are unlikely to pay attention to promotional and educational messaging, so the final strategy of promoting awareness is likely to be problematic.” I do not understand why promoting awareness is likely to be problematic. Do the authors mean ineffective? Or that promoting awareness is likely to cause resistance to the measure? This can be made clearer.

4. On page 8 line 171: it seems to me that people with high involvement with the policy outcome will not be complacent with respect to the risk. They are familiar for example with COVID and its risks and are concerned about it, but are not familiar with the vaccine as the intervention. Perhaps the authors should explain why they think people in the different quadrants have these levels of the C5.

5. On page 9 line 188: “Consequently, a strategy for promoting compliance among individuals in this quadrant with a favourable attitude might focus on self-regulation, using mechanisms such as voluntary codes of conduct.” I am not sure I understand what voluntary codes of conduct mean in this case, and why they are necessary if the people in question are already likely to comply.

6. In quadrants 3 and 4, the authors assume that collective responsibility involves getting vaccinated. This may not be the case; some of those opposing the vaccine believe it is better for people to not get vaccinated (e.g., they believe the vaccines are dangerous to young people, again an option mentioned in the current survey). If the authors argue that collective responsibility is only linked to adopting the measure rather than other altruistic intentions (even if misguided), they should clarify this point.

7. I believe that the discussion of enforcing vaccines should be done more carefully given the current debate on the issue. The other alternatives for increasing compliance among Q3 people with unfavorable attitudes towards COVID vaccines are dismissed as ineffective, but not enforcement. This topic is well-covered in the discussion, so I think the introduction should also present the compliance issues with enforcement.

8. It is unclear to me how someone can have favorable attitudes towards the COVID-19 vaccine without being involved with wanting to prevent the disease. Perhaps the authors could provide an example?

9. I thank the authors for providing the information about vaccinations in New Zealand.

10. The authors introduce the five components of involvement in the methods section, but this was not mentioned before. If the authors are not interested in presenting these components in detail in the introduction, they can briefly describe each component in the methods.

11. Based on the description of the measures, it seems like there was only one measure of involvement. The supplement material has two involvement scales, which makes it clear how the quadrants were determined. In order to help the reader who may not read the supplement material, I suggest clarifying that both types of involvement were measured.

12. In the first stage of analysis, there seems to be no separation between favorable and unfavorable attitudes towards the vaccine in the relevant quadrants. Was this planned or due to the small proportion of unfavorable attitudes in the sample?

13. I suggest that the authors use item means in their tables instead of the scores on the individual items. This will help reduce the number of tables and make them clearer.

14. On page 28: since the authors explain the clustering technique in the methods section, they do not have to mention it again in the results section.

15. I thank the authors for including the standardized coefficients in their tables reporting the regression results. Note that when reporting standardized coefficients, the intercept is always zero. If the authors want to include the intercept they should have separate columns for standardized and unstandardized parameters.

16. If the benchmark group is skeptics, then the results’ description should reflect that. For example, respondents with ambivalent beliefs about COVID had less favorable attitudes in comparison to the skeptics, not all of the other respondents.

Reviewer #3: (No Response)

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Zeeshan Asghar

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Apr 7;17(4):e0266485. doi: 10.1371/journal.pone.0266485.r004

Author response to Decision Letter 1


1 Mar 2022

Reviewer #2 comments:

1. The paper still suffers from minor organization issues. For example, the authors introduce the 5C framework but then say that the study uses the I3 framework, without explaining what it is and how they are connected until much later, or discuss the 5C model among people in quadrant 3 with unfavorable attitudes towards the measure before discussing those attitudes.

We have replaced the discussion of the 5C model in the Introduction with a short statement referring to vaccine hesitancy generally. We introduce the components of vaccine hesitancy in the description of the I3 Framework (quadrant 1 in particular) to assist the reader to better understand the implications of Framework. See revised lines 46-61, 124-125 and 143-159 (in the manuscript with track changes). We hope the restructure improves the readability of the manuscript.

Regarding attitudes towards being vaccinated among people in quadrant 3. The discussion here is intended to illustrative and we are suggesting some hypotheses about these people regarding the components of vaccine hesitance, simply on the basis of their involvement and whether their attitude is favourable or unfavourable. Hopefully we have made the illustrative nature of this discussion clearer by amending lines 214-215 (in the manuscript with track changes).

2. The way I understand Kaine et al. (2010), involvement with the issue in this context does not necessarily mean wanting to prevent the spread of COVID, but rather interest and research on the topic and involvement in decision-making related to it. One might conduct their own research and deduce that COVID is not very dangerous, an option addressed in the scales used in this study. This places them in the third quadrant (with unfavorable views), however, the description of this quadrant does not fit them. Could the authors please clarify the meaning of involvement with the issue, and if I understood correctly, adjust the quadrants’ descriptions accordingly?

We believe the reviewer is confusing involvement with Covid-19 per se and involvement with the policy outcome of eliminating Covid-19 from New Zealand. We have revised the definition of involvement with the policy outcome to clarify we are considering involvement with the outcome of elimination (lines 106-109 in the manuscript with track changes). Consequently, the quadrant descriptions do not require changing.

3. On page 7 line 158: “because people in this quadrant are uninterested, they are unlikely to pay attention to promotional and educational messaging, so the final strategy of promoting awareness is likely to be problematic.” I do not understand why promoting awareness is likely to be problematic. Do the authors mean ineffective? Or that promoting awareness is likely to cause resistance to the measure? This can be made clearer.

We have changed ‘problematic’ to ‘ineffective’ (line 177 in the manuscript with track changes).

4. On page 8 line 171: it seems to me that people with high involvement with the policy outcome will not be complacent with respect to the risk. They are familiar for example with COVID and its risks and are concerned about it, but are not familiar with the vaccine as the intervention. Perhaps the authors should explain why they think people in the different quadrants have these levels of the C5

We have revised the relevant paragraph (lines 191-192 in manuscript with track changes) to include reasons why people with high involvement in the policy outcome may be complacent with respect to risk of infection.

5. On page 9 line 188: “Consequently, a strategy for promoting compliance among individuals in this quadrant with a favourable attitude might focus on self-regulation, using mechanisms such as voluntary codes of conduct.” I am not sure I understand what voluntary codes of conduct mean in this case, and why they are necessary if the people in question are already likely to comply.

Codes of conduct may be an appropriate mechanism in other contexts (e.g. occupational health and safety) but are not relevant in this context as the reviewer points out. We thought the simplest solution was to delete mention of this mechanism from the paragraph (line 209 in the manuscript with track changes).

6. In quadrants 3 and 4, the authors assume that collective responsibility involves getting vaccinated. This may not be the case; some of those opposing the vaccine believe it is better for people to not get vaccinated (e.g., they believe the vaccines are dangerous to young people, again an option mentioned in the current survey). If the authors argue that collective responsibility is only linked to adopting the measure rather than other altruistic intentions (even if misguided), they should clarify this point.

In models of vaccine hesitancy such as the 5C model, ‘collective responsibility’ refers specifically to ‘a willingness to protect others by getting vaccinated’ (see line 155 in the manuscript with track changes). We have added this qualifier at lines 221 and 282 in the manuscript with track changes).

7. I believe that the discussion of enforcing vaccines should be done more carefully given the current debate on the issue. The other alternatives for increasing compliance among Q3 people with unfavorable attitudes towards COVID vaccines are dismissed as ineffective, but not enforcement. This topic is well-covered in the discussion, so I think the introduction should also present the compliance issues with enforcement.

In the theory section we describe a number of alternatives for increasing compliance among Q3 with unfavourable attitudes with enforcement mentioned as one alternative. We did not conclude the alternatives to enforcement would be ineffective., though we did note they might be unsuccessful if people engage in motivated reasoning. To avoid appearing to advocate enforcement too forcefully we have qualified the suggestion of enforcement in relation to Q3 (and Q4) with unfavourable attitudes by noting the imposition of blanket penalties for non-compliance may run the risk of incidentally alienating people with low involvement (see lines 242-244 and 269-271 in the manuscript with track changes).

We did note that if the causes of non-compliance relate to unpredictable variations in the environment, or to unforeseeable technical problems, then enforcement and general deterrence may be ineffective, and the provision of technical assistance would be more appropriate; one could imagine this might translate into alternative healthcare arrangements for example (see lines 246-249 in the manuscript with track changes).

8. It is unclear to me how someone can have favorable attitudes towards the COVID-19 vaccine without being involved with wanting to prevent the disease. Perhaps the authors could provide an example?

We presume the Reviewer is referring to the possibility of a person in quadrant 4 with a favourable attitude towards vaccination but low involvement with eliminating Covid-19. The key here is that having a favourable attitude does not necessarily mean one is highly motivated. One may have a favourable attitude towards vaccination, that does not mean one necessarily cares strongly about ‘eliminating Covid-19 from New Zealand’. For example, a person who views vaccination purely in terms of personal protection may favour vaccination but be disinterested in the outcome of eliminating Covid-19. Presumably such a person will have a limited sense of collective responsibility in the 5C sense. We have amended the relevant paragraph to include this example (see lines 277-278 in the manuscript with track changes) and thank the reviewer for bringing this opportunity to clarify to our attention.

9. I thank the authors for providing the information about vaccinations in New Zealand.

10. The authors introduce the five components of involvement in the methods section, but this was not mentioned before. If the authors are not interested in presenting these components in detail in the introduction, they can briefly describe each component in the methods.

We have added a brief definition of the five components of involvement to the Methods section (see lines 327-332 in the manuscript with track changes).

11. Based on the description of the measures, it seems like there was only one measure of involvement. The supplement material has two involvement scales, which makes it clear how the quadrants were determined. In order to help the reader who may not read the supplement material, I suggest clarifying that both types of involvement were measured.

We have revised the relevant paragraph to be clear both types of involvement were measured (see lines 323-324 in the manuscript with track changes).

12. In the first stage of analysis, there seems to be no separation between favorable and unfavorable attitudes towards the vaccine in the relevant quadrants. Was this planned or due to the small proportion of unfavorable attitudes in the sample?

The proportion of respondents with favourable and unfavourable attitudes towards vaccination in each quadrant is reported in Table 3. As the reviewer observes, fundamentally, the proportion of unfavourable responses in the sample was too small to generate significant results. Furthermore, the data used to generate the results reported in Tables 5 and 6 was restricted to respondents who indicated that they definitely would, probably would, or might get vaccinated.

13. I suggest that the authors use item means in their tables instead of the scores on the individual items. This will help reduce the number of tables and make them clearer.

We believe the reviewer is referring to Tables 8 and 9 where we present results showing differences across the quadrants with respect to items from the survey that we believe related to the components of the 5C model. We prefer not to summarise these tables as suggested because the variables were not intended to be scales for measuring the 5C components and are not the standard scale items used in 5C model (these qualifications are made at lines 520-522 in the manuscript with track changes). By presenting the mean scores for each variable (rather than aggregating them into scales) the reader is in a position to judge for themselves whether the variables we report reflect the 5C components and judge the results accordingly.

14. On page 28: since the authors explain the clustering technique in the methods section, they do not have to mention it again in the results section.

We have revised the relevant paragraphs in the Methods and Results to remove the repetition (see lines 427-429 and lines 563-566 in the manuscript with track changes).

15. I thank the authors for including the standardized coefficients in their tables reporting the regression results. Note that when reporting standardized coefficients, the intercept is always zero. If the authors want to include the intercept, they should have separate columns for standardized and unstandardized parameters.

We have removed reporting of intercepts in the relevant tables (Tables 9-13 in the manuscript with track changes).

16. If the benchmark group is skeptics, then the results’ description should reflect that. For example, respondents with ambivalent beliefs about COVID had less favorable attitudes in comparison to the skeptics, not all of the other respondents.

We have revised the relevant paragraph Results to state beliefs about Covid-19 itself did not strongly influence attitude toward eliminating Covid-19 in New Zealand over and above beliefs about elimination (see lines 736-739 in the manuscript with track changes).

Attachment

Submitted filename: Response to reviewers march.docx

Decision Letter 2

Sonia Brito-Costa

22 Mar 2022

Predicting willingness to be vaccinated for Covid-19: evidence from New Zealand

PONE-D-21-33647R2

Dear Dr. Kaine,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sonia Brito-Costa, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: I thank the authors for addressing all of my comments. I believe the manuscript is now ready for publication, with the exception of a minor correction I believe to be a typo: In line 220, I think people in Q3 (and Q4) who have unfavorable attitudes should be sensitive to constraints on being vaccinated, which is one of the reasons they have unfavorable attitudes. The authors also mention that they are sensitive to the policy’s costs in the next paragraph, strengthening this point. If I misunderstood, the authors can clarify what they mean by insensitivity to costs among those groups. Otherwise, I wish the authors good luck in their future endeavors.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Sonia Brito-Costa

24 Mar 2022

PONE-D-21-33647R2

Predicting willingness to be vaccinated for Covid-19: evidence from New Zealand

Dear Dr. Kaine:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Sonia Brito-Costa

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Questionnaire.

    (DOCX)

    S2 File. Data.

    (XLSX)

    S1 Appendix

    (PDF)

    S2 Appendix

    (PDF)

    Attachment

    Submitted filename: Response to reviewers january.docx

    Attachment

    Submitted filename: Response to reviewers march.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES